Financials and Filings FINANCIALS AND FILINGS submenu Overview SEC Filings Annuals & Proxies Quarterly Results Key Ratios Show all 2024 Third Quarter Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance Form 10-Q Filing date View October 30, 2024 View HTML 0001628280-24-044196.pdf 0001628280-24-044196.rtf 0001628280-24-044196.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA August 07, 2024 View HTML 0001628280-24-035386.pdf 0001628280-24-035386.rtf 0001628280-24-035386.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-K Filing date View February 22, 2024 View HTML 0001628280-24-006156.pdf 0001628280-24-006156.rtf 0001628280-24-006156.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA March 01, 2023 View HTML 0001193125-23-055176.pdf 0001193125-23-055176.rtf 0001193125-23-055176.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Proxy Statements Filing date View April 29, 2024 View HTML 0001628280-24-018986.pdf 0001628280-24-018986.xls 0001628280-24-018986.rtf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA April 28, 2023 View HTML 0001193125-23-127257.pdf 0001193125-23-127257.xls 0001193125-23-127257.rtf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
